176 related articles for article (PubMed ID: 18557900)
21. TIP47 is required for the production of infectious HIV-1 particles from primary macrophages.
Bauby H; Lopez-Vergès S; Hoeffel G; Delcroix-Genête D; Janvier K; Mammano F; Hosmalin A; Berlioz-Torrent C
Traffic; 2010 Apr; 11(4):455-67. PubMed ID: 20070608
[TBL] [Abstract][Full Text] [Related]
22. Peptide inhibitors of HIV-1 egress.
Waheed AA; Freed EO
ACS Chem Biol; 2008 Dec; 3(12):745-7. PubMed ID: 19099395
[TBL] [Abstract][Full Text] [Related]
23. Dynamic analysis of genetic diversity of gag and env regions of HIV-1 CRF07_BC recombinant in intravenous drug users in Xinjiang Uvghur Autonomous Region, China.
Liu S; Xing H; He X; Xin R; Zhang Y; Zhu J; Shao Y
Arch Virol; 2008; 153(7):1233-40. PubMed ID: 18504522
[TBL] [Abstract][Full Text] [Related]
24. Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner.
Hahn F; Schmalen A; Setz C; Friedrich M; Schlößer S; Kölle J; Spranger R; Rauch P; Fraedrich K; Reif T; Karius-Fischer J; Balasubramanyam A; Henklein P; Fossen T; Schubert U
PLoS One; 2017; 12(4):e0174254. PubMed ID: 28388673
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 matrix protein: a mysterious regulator of the viral life cycle.
Bukrinskaya A
Virus Res; 2007 Mar; 124(1-2):1-11. PubMed ID: 17210199
[TBL] [Abstract][Full Text] [Related]
26. Assembly of the HIV-1 core particle.
Kaplan AH
AIDS Rev; 2002; 4(2):104-11. PubMed ID: 12152518
[TBL] [Abstract][Full Text] [Related]
27. Methods for the study of HIV-1 assembly.
Waheed AA; Ono A; Freed EO
Methods Mol Biol; 2009; 485():163-84. PubMed ID: 19020825
[TBL] [Abstract][Full Text] [Related]
28. Proteome analysis of the HIV-1 Gag interactome.
Engeland CE; Brown NP; Börner K; Schümann M; Krause E; Kaderali L; Müller GA; Kräusslich HG
Virology; 2014 Jul; 460-461():194-206. PubMed ID: 25010285
[TBL] [Abstract][Full Text] [Related]
29. [The action of TSG101 on HIV-1 budding and related inhibitors].
Chen HF; Liu XY
Yao Xue Xue Bao; 2008 Dec; 43(12):1165-70. PubMed ID: 19244744
[TBL] [Abstract][Full Text] [Related]
30. Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.
Staubus AO; Alfadhli A; Barklis RL; Barklis E
Virology; 2019 Dec; 538():1-10. PubMed ID: 31550607
[TBL] [Abstract][Full Text] [Related]
31. A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line.
Grigorov B; Attuil-Audenis V; Perugi F; Nedelec M; Watson S; Pique C; Darlix JL; Conjeaud H; Muriaux D
Retrovirology; 2009 Mar; 6():28. PubMed ID: 19284574
[TBL] [Abstract][Full Text] [Related]
32. Super-Resolution STED Microscopy-Based Mobility Studies of the Viral Env Protein at HIV-1 Assembly Sites of Fully Infected T-Cells.
Chojnacki J; Eggeling C
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918253
[TBL] [Abstract][Full Text] [Related]
33. HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.
Monel B; Beaumont E; Vendrame D; Schwartz O; Brand D; Mammano F
J Virol; 2012 Apr; 86(7):3924-33. PubMed ID: 22258237
[TBL] [Abstract][Full Text] [Related]
34. Human Ubc9 is involved in intracellular HIV-1 Env stability after trafficking out of the trans-Golgi network in a Gag dependent manner.
Bohl CR; Abrahamyan LG; Wood C
PLoS One; 2013; 8(7):e69359. PubMed ID: 23861967
[TBL] [Abstract][Full Text] [Related]
35. Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.
Ritchie C; Cylinder I; Platt EJ; Barklis E
J Virol; 2015 Apr; 89(7):3988-4001. PubMed ID: 25631074
[TBL] [Abstract][Full Text] [Related]
36. Evidence that Gag facilitates HIV-1 envelope association both in GPI-enriched plasma membrane and detergent resistant membranes and facilitates envelope incorporation onto virions in primary CD4+ T cells.
Patil A; Gautam A; Bhattacharya J
Virol J; 2010 Jan; 7():3. PubMed ID: 20064199
[TBL] [Abstract][Full Text] [Related]
37. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
Neil SJ; Zang T; Bieniasz PD
Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
[TBL] [Abstract][Full Text] [Related]
38. Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy.
Joshi A; Garg H; Ablan S; Freed EO; Nagashima K; Manjunath N; Shankar P
Virology; 2011 Jul; 415(2):95-106. PubMed ID: 21529874
[TBL] [Abstract][Full Text] [Related]
39. Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail.
Muranyi W; Malkusch S; Müller B; Heilemann M; Kräusslich HG
PLoS Pathog; 2013 Feb; 9(2):e1003198. PubMed ID: 23468635
[TBL] [Abstract][Full Text] [Related]
40. A mouse model based on replication-competent Tiantan vaccinia expressing luciferase/HIV-1 Gag fusion protein for the evaluation of protective efficacy of HIV vaccine.
Huang Y; Qiu C; Liu LX; Feng YM; Zhu T; Xu JQ
Chin Med J (Engl); 2009 Jul; 122(14):1655-9. PubMed ID: 19719967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
